Bacil Pharma Q1 Results

  • BSE: 524516
  • NSE: -
  • ISIN: INE711D01018
  • Sector: Biotechnology & Drugs
BSE
45.170.87 (1.96%)
Volume7.30 K
Updated: Tue 26 Nov, 2024 | 15:15:00
NSE
This stock is not traded on NSE
Today: 43.42
45.18
52-Wk: 4.68
50.02

Q1 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Bacil Pharma Q1 Results

    *All figures in crores except per share values
    Fiscal PeriodJun 24Mar 24QoQ Comp
    Total Revenue 0.000.00-%
    Selling/ General/ Admin Expenses Total 0.020.04-%
    Depreciation/ Amortization 0.000.00-%
    Other Operating Expenses Total 0.020.03-%
    Total Operating Expense 0.040.06-%
    Operating Income -0.04-0.06-%
    Net Income Before Taxes -0.03-0.04-%
    Net Income -0.03-0.04-%
    Diluted Normalized EPS -0.06-0.08-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts